Genomic characterization of metastatic breastcancers.
François Bertucci,Charlotte K Y Ng,+25 authors, Anne Patsouris,Nathalie Droin,Salvatore Piscuoglio,Nadine Carbuccia,Jean Charles Soria,Alicia Tran Dien,Yahia Adnani,Maud Kamal,Séverine Garnier,Guillaume Meurice,Marta Jimenez,Semih Dogan,Benjamin Verret,Max Chaffanet,Thomas Bachelot,Mario Campone,Claudia Lefeuvre,Herve Bonnefoi,Florence Dalenc,Alexandra Jacquet,Maria R De Filippo,Naveen Babbar,Daniel Birnbaum,Thomas Filleron,Christophe Le Tourneau,Fabrice André. less Nature.
2019 May 22; 569(7757):560-564.
PMID: 31118521
Highly Cited.
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breastcancer.
P Tarantino,G Viale,+29 authors, M F Press,X Hu,F Penault-Llorca,A Bardia,A Batistatou,H J Burstein,L A Carey,J Cortes,C Denkert,V Diéras,W Jacot,A K Koutras,A Lebeau,S Loibl,S Modi,M F Mosele,E Provenzano,G Pruneri,J S Reis-Filho,F Rojo,R Salgado,P Schmid,S J Schnitt,S M Tolaney,D Trapani,A Vincent-Salomon,A C Wolff,G Pentheroudakis,F André,G Curigliano. less Ann Oncol.
2023 Jun 01; 34(8):645-659.
PMID: 37269905
Review.
Dissecting the heterogeneity of triple-negative breastcancer.
Otto Metzger-Filho,Andrew Tutt,+11 authors, Evandro de Azambuja,Kamal S Saini,Giuseppe Viale,Sherene Loi,Ian Bradbury,Judith M Bliss,Hatem A Azim,Paul Ellis,Angelo Di Leo,José Baselga,Christos Sotiriou,Martine Piccart-Gebhart. less J Clin Oncol.
2012 Mar 26; 30(15):1879-87.
PMID: 22454417
Highly Cited.
Review.